NGS-Based RNA-Sequencing Market Analysis, Insight, & Scope for Expand to Latest Development by 2029

NGS-based RNA-seq is widely employed for sophisticated and comprehensive genomic insights in both standard and non-traditional applications. The growing demand for better sequencing-based diagnostics has fueled the development of novel sequencing technologies. As a result, demand for technologies like high-throughput sequencers and portable units has skyrocketed. The market for NGS-based RNA-seq is increasing due to a number of causes, including technological developments in RNA-seq products, the advantages of RNA-seq over microarray technology, rapid expansion in research activities, an increase in RNA-seq awards, and a high need for precision medicine.
Data Bridge Market Research analyses that the NGS-based RNA-sequencing market which was USD 2.44 billion in 2021, would rocket up to USD 10.42 billion by 2029, and is expected to undergo a CAGR of 19.90% during the forecast period 2022 to 2029. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Asceses Full report@- https://www.databridgemarketresearch.com/reports/global-ngs-based-rna-sequencing-market

Global NGS-based RNA-sequencing market is segmented on the basis of type, skin site and diseases. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Product and Service
• Sample Preparation Products
• Sequencing Platforms and Consumables
• Sequencing Services
• Data Analysis, Storage, and Management
Technology
• Sequencing by Synthesis
• Ion Semiconductor Sequencing
• Single-molecule Real-time Sequencing
• Nanopore Sequencing
Application
• Expression Profiling Analysis
• Small RNA Sequencing
• De Novo Transcriptome Assembly
• Variant Calling and Transcriptome Epigenetics
End User
• Research and Academia
• Hospitals and Clinics
• Pharmaceutical and Biotechnology Companies
• Other End Users

Related Report@-
https://jondevide92.blogspot.com/2024/01/medical-tapes-and-bandages-market.html
https://jondevide92.blogspot.com/2024/01/expression-vectors-market-insight.html
https://jondevide92.blogspot.com/2024/01/speciality-enzymes-market-growth.html
https://jondevide92.blogspot.com/2024/01/wearable-fitness-trackers-market-growth.html

Some of the major players operating in the NGS-based RNA-sequencing market are:
• Illumina Inc. (US)
• Thermo Fischer Scientific Inc. (US)
• Oxford Nanopore Technologies plc (UK)
• Agilent Technologies, Inc. (US)
• BGI (China)
• PerkinElmer Inc. (US)
• QIAGEN (Germany)
• Eurofins Scientific (Luxembourg)
• F. Hoffmann-La Roche Ltd (Switzerland)
• Takara Bio Inc. (Japan)
• GENEWIZ, Inc. (US)
• Hamilton Company (US)
• Macrogen Inc. (South Korea)
• Zymo Research Corporation (US)
• Tecan Trading AG (Switzerland)

Data Bridge Market Research has over 500 analysts working in different industries. We have catered more than 40% of the fortune 500 companies globally and have a network of more than 5000+ clientele around the globe. Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. We are content with our glorious 99.9 % client satisfying rate.

Contact Us:-
Data Bridge Market Research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
Email:- corporatesales@databridgemarketresearch.com

This release was published on openPR.